MedPath

Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT)

Completed
Conditions
Intrauterine Growth Failure
Pregnancy and Childbirth
Registration Number
ISRCTN10363217
Lead Sponsor
eiden University Medical Centre (LUMC) (Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
600
Inclusion Criteria

1. Women with a presumed diagnosis of growth failure greater than 36 completed weeks
2. Women are identified initially by clinical assessment of foetal growth between 35 and 39 weeks. After identification, patients will be referred for foetal biometry, a non-stress test and Doppler ultrasound of the umbilical artery and the a. cerebri media
3. Patients in whom the diagnosis of growth failure greater than 36 is confirmed, and in whom the obstetrician is uncertain whether delivery is indicated or not are eligible for the study
4. The final entry criteria are an accurate ultrasound dating scan before 20 weeks and clinical suspicion of failure to thrive in-utero after 36 completed weeks or later, while the clinician is uncertain whether to induce or to await spontaneous delivery

Exclusion Criteria

1. Multiple pregnancy
2. Obstetrical history with caesarean section
3. Breech
4. Inaccurate dating of gestational age
5. Suspected congenital malformation
6. Foetal distress needing delivery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
nder the condition of equal short-term neonatal outcome, the primary outcome will be the number of obstetrical interventions. <br><br>Neonatal outcome: <br>1. Umbilical cord pH less than 7.10<br>2. Base Excess less than -10 <br>3. Apgar at 5 minutes less than 7<br>4. Neonatal admittance to Neonatal Intensive Care Unit (NICU)
Secondary Outcome Measures
NameTimeMethod
1. Costs<br>2. Assessment of children later in life; postal enquiries as the Child Behavior Checklist (CBCL) and Ages and Stages Questionnaire (ASQ) will be used
© Copyright 2025. All Rights Reserved by MedPath